[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-337282-105":59,"doc-detail-337282-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","exosomal-proteomics-unveiling-novel-insights-into-lung-cancer","Exosomal Proteomics: Unveiling Novel Insights into Lung Cancer","","Early lung cancer screening has advanced, yet lung cancer remains among the most common and lethal cancers globally. Exosomal proteomics is emerging as a precision-medicine approach to reshape diagnostics, prognostic evaluation, and therapeutic planning. This review summarizes recent developments in exosome-related proteomic and glycoproteomic technologies, emphasizing heterogeneity resolution, integration of multiomics data, and advanced analytical methods. Despite promise, standardization, clinical gaps, and the need for dynamic monitoring remain key barriers before broad implementation.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/exosomal-proteomics-unveiling-novel-insights-into-lung-cancer/337282/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/exosomal-proteomics-unveiling-novel-insights-into-lung-cancer/337282.png","ImageObject",300,407,{"name":92,"@type":93},"Valentina","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-24","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is early lung cancer detection still a major clinical challenge?","Question",{"text":112,"@type":113},"Early detection rates remain low, especially in high-risk groups, largely due to limitations of current diagnostic approaches and the low specificity of some screening methods. This contributes to late-stage diagnosis and poor outcomes.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does liquid biopsy relate to exosomal proteomics in lung cancer research?",{"text":117,"@type":113},"Liquid biopsy enables analysis of circulating tumor elements, including exosomes. Exosome cargo such as nucleic acids, proteins, and lipids supports intercellular communication and can reflect disease processes, making exosome-based profiling valuable.",{"name":119,"@type":110,"acceptedAnswer":120},"Which technical directions are highlighted for improving exosomal proteomics?",{"text":121,"@type":113},"The review emphasizes advances in proteomics and glycoproteomics technologies, particularly mass spectrometry-based methods. It also highlights the need to address tumor heterogeneity and integrate multiomics data using advanced analytical tools.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},337282,1791158131,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},13056703020460,"https://ap-avatar.wpscdn.com/avatar/be000253dac470eee5d?_k=1778207105932848923","Volume 16, Number 2; 876-900 April 2025  \n[http://dx.doi.org/10.14336/AD.2024.0409](http://dx.doi.org/10.14336/AD.2024.0409)  \nReview  \nExosomal Proteomics: Unveiling Novel Insights into Lung  \nCancer  \nGuanhua Yi1\\#, Haixin Luo1\\#, Yalin Zheng1, Wenjing Liu1, Denian Wang1, 2*, Yong Zhang1*  \n1Department of Pulmonary and Critical Care Medicine and Institutes for Systems Genetics, West China Hospital, Sichuan University, Chengdu 610041, China. 2Precision Medicine Center, Precision Medicine Key Laboratory of Sichuan Province, West China Hospital, Sichuan University, Chengdu 610041, China.  \n[Received March 11, 2024; Revised April 8, 2024; Accepted April 9, 2024]  \nABSTRACT: Although significant progress has been made in early lung cancer screening over the past decade, it remains one of the most prevalent and deadliest forms of cancer worldwide. Exosomal proteomics has emerged as a transformative field in lung cancer research, with the potential to redefine diagnostics, prognostic assessments, and therapeutic strategies through the lens of precision medicine. This review discusses recent advances in exosomerelated proteomic and glycoproteomic technologies, highlighting their potential to revolutionise lung cancer treatment by addressing issues of heterogeneity, integrating multiomics data, and utilising advanced analytical methods. While these technologies show promise, there are obstacles to overcome before they can be widely implemented, such as the need for standardization, gaps in clinical application, and the importance of dynamic monitoring. Future directions should aim to overcome the challenges to fully utilize the potential of exosomal proteomics in lung cancer. This promises a new era of personalized medicine that leverages the molecular complexity of exosomes for groundbreaking advancements in detection, prognosis, and treatment.  \nKey words: lung cancer, exosome, mass spectrometry, proteomics  \n1. Introduction  \nGlobally, lung cancer remains the leading cause of cancer incidence and mortality, with an estimated 2.207 million new cases and 1.796 million deaths in 2020 alone. This represents 11.4% of all new cancer cases and 18.0% of all cancer-related deaths worldwide, underscoring the critical challenge lung cancer poses to global health [1] . Lung cancer primarily manifests as small cell lung cancer (SCLC), representing 15%, and non-small cell lung cancer (NSCLC), accounting for 80% of lung cancer cases [2] . Furthermore, NSCLC can be classified as lung adenocarcinoma (LUAD), lung squamous carcinoma (LUSC), large cell carcinoma, or bronchial carcinoid carcinoma, with LUAD being the most widespread subtype. Most SCLC patients are diagnosed with metastasis, challenging the effectiveness of current treatments such as radiotherapy and chemotherapy [3, 4] .  \nNSCLC often goes undetected until the advanced stage, with only a 4% five-year survival rate for late-stage diagnosis compared to 83% for stage I. This stark contrast underscores the critical need for early detection in highrisk groups to improve patient outcomes [5] . The essential role of early screening and diagnosis in improving lung cancer survival cannot be overstated, especially for highrisk groups. Currently, the early detection rate is only 15%, hampered by the shortcomings of available diagnostic approaches [6]. While tissue biopsy, including methods such as fiberoptic bronchoscopy and imageguided transthoracic puncture, is pivotal for diagnosing lung cancer, these techniques are not only expensive but also fraught with potential complications and often necessitate multiple samples, imposing both physical and financial strain on patients. Conversely, low-dose spiral computed tomography (CT), despite its utility in early detection, suffers from low specificity and a heightened  \n\n| rate of false positives, with the added caveat of increased cancer risk due to radiation exposure [7, 8] . This landscape, however, is poised for transformation with the advent o","cbCaiqca5q4ON9Aj","https://ap.wps.com/l/cbCaiqca5q4ON9Aj","pdf",906036,25,"English","# Introduction\n# Exosomes and Liquid Biopsy\n# Exosomal Proteomics Technologies\n# Challenges and Clinical Implementation\n# Future Directions","[{\"question\":\"Why is early lung cancer detection still a major clinical challenge?\",\"answer\":\"Early detection rates remain low, especially in high-risk groups, largely due to limitations of current diagnostic approaches and the low specificity of some screening methods. This contributes to late-stage diagnosis and poor outcomes.\"},{\"question\":\"How does liquid biopsy relate to exosomal proteomics in lung cancer research?\",\"answer\":\"Liquid biopsy enables analysis of circulating tumor elements, including exosomes. Exosome cargo such as nucleic acids, proteins, and lipids supports intercellular communication and can reflect disease processes, making exosome-based profiling valuable.\"},{\"question\":\"Which technical directions are highlighted for improving exosomal proteomics?\",\"answer\":\"The review emphasizes advances in proteomics and glycoproteomics technologies, particularly mass spectrometry-based methods. It also highlights the need to address tumor heterogeneity and integrate multiomics data using advanced analytical tools.\"}]","Exosomal Proteomics: Unveiling Novel Insights into Lung Cancer | PDF",1790018477,63,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9b15cfbae2061324445cfe136beabe60.webp",983,1272,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f4677ef9141e880030834ce491e4b4e2.webp",982,1270,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/60974475d2d3f7d1a2b7229918748e1a.webp",981,1269,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/77dcec0bbb5fa185f38affdab5f863a4.webp",980,1268]